Form 4 for PHAT Phathom Pharmaceuticals, Inc.
Accepted 2025-09-09 00:00:00 ET · period of report 2025-09-05 · accession 0000950170-25-113822 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-09 | 2025-09-05 | PHAT | Breedlove Robert Charles | Principal Accounting Off | S - Sale | $12.09 | -461 | 47.9K | -1.0% | -$5,573 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-05 | S | D | 461 | $12.09 | 47,931 | D | — | — |